Apyx Medical Corporation
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It…
Medical - Devices
US, Clearwater [HQ]
Insiders
Transactions
Track non-derivative insider transactions.
i = Indirect Ownership
d = Direct Ownership
cs = Common Stock
| Reported Owner(s) | Position Now | Transaction Date | Type | Position Change | Extra | ||
|---|---|---|---|---|---|---|---|
|
$7,836
d
cs
10% Holder
|
08/13/24 |
P
|
5,336 x $1.13 = $6,029.68 |
Footnotes
#1 This transaction was executed in multiple trades at prices ranging from $1.12 to $1.13. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
|
|||
|
$2,500
d
cs
10% Holder
|
12/12/23 |
P
|
2,500 x $2.19 = $5,475.00 |
Footnotes
#1 This transaction was executed in multiple trades at prices ranging from $2.14 to $2.22. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
|
|||
|
$90,000
d
cs
10% Holder
|
11/14/23 |
P
|
50,000 x $1.57 = $78,500.00 |
Footnotes
#1 This transaction was executed in multiple trades at a prices ranging from $1.56 to $1.57. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
|
|||
|
$5,338
i
cs
10% Holder
|
07/12/23 |
M
|
5,338 x $2.97 = $15,853.86 |
Footnotes
#1 Represents a "net exercise" of outstanding stock options. The Reporting Person received 5,338 shares of common stock on net exercise of an option to purchase 12,000 shares of common stock.
#2 The Reporting Person transferred this option to a Spousal Lifetime Access Trust (the "SLAT"). The Reporting Person's spouse and children are trustees of the SLAT.
#3 The Reporting Person disclaims beneficial ownership of all securities held by the SLAT, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein, if any.
|
|||
|
$40
d
cs
10% Holder
|
06/26/23 |
S
|
15,000 x $7.56 = $113,400.00 |
Footnotes
#1 The reported sale occurred automatically pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on March 21, 2023.
#2 This transaction was executed in multiple trades at prices ranging from $7.30 to $7.70. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
|
|||
Get PRO Today
With PRO you will unlock 13 more insider transactions for Apyx Medical Corporation
Statistics
Sample Size: 18 Transactions
Sale (S)
15,000 Shares
5.56%
Buy (P)
69,586 Shares
27.78%
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture:
- Andres John C. Director
- Baylor-Henry Minnie Director
- Citronowicz Moshe Sr. V.P. of Operations
- Geraghty Michael Director
- Goodwin Charles D. Ii Chief Executive Officer
- Hill Matthew C Chief Financial Officer
- Hornsby Todd Executive Vice President
- Levine Wendy Lauren Director
- Makrides Andrew Director
- Semb Tara Chief Financial Officer
- Swandal Craig A. Director
- Vizirgianakis Stavros G. Director
- Waldman Lawrence Director
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture:
- Andres John C. Director
- Baylor-Henry Minnie Director
- Citronowicz Moshe Sr. V.P. of Operations
- Geraghty Michael Director
- Goodwin Charles D. Ii Chief Executive Officer
- Hill Matthew C Chief Financial Officer
- Hornsby Todd Executive Vice President
- Levine Wendy Lauren Director
- Makrides Andrew Director
- Semb Tara Chief Financial Officer
- Swandal Craig A. Director
- Vizirgianakis Stavros G. Director
- Waldman Lawrence Director